多発性骨髄腫におけるオートファジーの重要性
Martyna Bednarczyk1, Nicola Dąbrowska-Szeja1, Dariusz Łętowski1
1Department of Cancer Prevention, Faculty of Public Health, Silesian Medical University, Katowice, Poland.
Expert review of anticancer therapy
|December 28, 2025
まとめ
オートファジーは細胞プロセスであり、多発性骨髄腫(MM)の発症と進行において複雑な役割を果たしています。オートファジーを標的とすることは、新しいMMの診断と治療の可能性を提供します。
科学分野:
- 細胞生物学
- 腫瘍学
- 免疫学
背景:
- オートファジーは、損傷したタンパク質およびオルガネラの分解に関与する基本的な細胞プロセスである。
- オートファジーの調節不全は、がんを含む様々な疾患に関与している。
- 以前の研究では、がんの病因におけるオートファジーの重要性が強調されている。
研究 の 目的:
- MM(多発性骨髄腫)の発症におけるオートファジーの役割をレビューする。
- UPR、BMME、薬剤耐性、低酸素症、DNA修復の文脈でMMにおけるオートファジーメカニズムを探求する。
- MMにおけるオートファジー関連遺伝子および経路内の潜在的な治療標的を特定する。
主な方法:
- PubMedおよびGoogle Scholarの体系的な文献検索。
- 多発性骨髄腫におけるオートファジーに関するメタアナリシス、症例対照研究、観察研究の分析。
- オートファジーメカニズムとMMへの関連性に関する現在の研究のレビュー。
主要な成果:
- オートファジーは、がんにおいて発がんを促進または阻害する可能性のある二面的な役割を示す。
- オートファジーは、B細胞の運命にとって重要であり、生存または細胞死に影響を与える。
- MMにおけるUPR、BMME、薬剤耐性、低酸素症、DNA修復との関連で、オートファジー調節について論じる。
結論:
- オートファジー遺伝子発現解析は、MMの診断と個別化治療に役立つ可能性がある。
- オートファジーの調節は、MMの進行を制限し、治療効果を高めるための有望な治療戦略を提供する。
- オートファジー経路を標的とすることは、MMの新しい分子標的療法につながる可能性がある。
関連する概念動画
Autophagy
5.6K
Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
5.6K
Delivery Pathways to the Lysosome
8.7K
Eukaryotic cells use different mechanisms to eliminate toxic waste obsolete and worn-out substances. Lysosomes play a pivotal role in this, and hence, these substances are carried to the lysosome from other parts of the cell and extracellular space through different pathways. The most elaborately studied pathways to the lysosome are the endocytic pathways.
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
8.7K
Autophagic Cell Death
4.3K
Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
4.3K
mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K
The Intrinsic Apoptotic Pathway
8.2K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
8.2K
Lysosomal Hydrolases
4.4K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
4.4K


